Please sign in with your existing account details.
Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.
Privacy statement - Terms and conditions
Forgotten your password?
You have exceeded the maximum number of login attempts for this email address and your account has been locked. An email has been sent to member of Browne Jacobson's web team and some one will be contacting you over the next two working days with details of how to change your password.
Are you sure you want to remove this item from you pinned content?
The Local Government Association (LGA) has warned that proposals to top-slice funding for disadvantaged children in England could backfire.
Currently the Early Intervention Grant (EIG) is paid by central government to local authorities (LAs) to support early years and family intervention programmes, including Sure Start Centres, parenting support and short breaks for disabled people. Under the proposals, which followed a 12 week consultation, the £2.3 billion grant will no longer be paid to LAs in the form of a separate grant, the cash instead being held centrally. Of the total grant £1.3bn will go to a ring fenced schools grant to pay for free nursery care for two year olds; £300m will be top-sliced by the DfE; and the remainder will be rolled into councils' central revenue stream.
Councils are concerned that the changes could lead to a 20% reduction in early intervention at a local level. If these fears are realised, this could have a serious impact on LA’s ability to deliver early intervention services.
With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.
View blog
The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.
Our top tips for supporting transgender and non-binary pupils.
On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.
Select which mailings you would like to receive from us.
Sign up